Judith Usall, MD, PhD, is affiliated with the Institut de Recerca Sant Joan de Déu and Parc Sanitari Sant Joan de Déu in Spain. Her publications, spanning from 2011 to 2024, focus on schizophrenia and schizoaffective disorders, anxiety, and major depressive disorder. She has studied topics including inflammatory biomarkers in first-episode psychosis, negative symptoms and cognitive functioning in psychosis, and adjunctive pharmacological treatments for schizophrenia. Her work has frequently involved collaboration with co-authors such as Iluminada Corripio and Mercedes Roca.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
